Major Ingredients

Moxifloxacin 400 mg as Moxifloxacin Hydrochloride USP Tablet.

Major Functionality

It is indicated for treating the following infections : Acute Bacterial Sinusitis, Acute Bacterial Exacerbation of Chronic Bronchitis, Community Acquired Pneumonia, Uncomplicated Skin and Skin Structure Infections, Complicated Skin and Skin Structure Infections, Complicated Intra-Abdominal Infections.

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.